Outcomes

Neurodevelopmental Outcomes in Children with Prenatal Exposure to Antiepileptic Drugs: A Systematic Review

A systematic review examines neurodevelopmental outcomes in children prenatally exposed to antiepileptic drugs.

By |2025-06-26T09:07:20-04:00May 1st, 2024|Anti-Epileptic Drugs, Neurodevelopmental Disorders, Outcomes, Pregnancy & Medications|Comments Off on Neurodevelopmental Outcomes in Children with Prenatal Exposure to Antiepileptic Drugs: A Systematic Review

Maternal Depression Negatively Affects Fetal Growth During Critical Stage of Development

In this prospective cohort study, the researchers observed an association between maternal depressive symptoms during pregnancy with slower rates of fetal growth.

By |2024-05-16T06:53:15-04:00April 2nd, 2024|Child Outcomes, Depressive Disorders, Outcomes, Psychiatric Disorders During Pregnancy|Comments Off on Maternal Depression Negatively Affects Fetal Growth During Critical Stage of Development

Research from the CWMH: Prenatal Exposure to Second Generation Antipsychotics and Neurodevelopmental Outcomes in Preschool-Aged Children

The current study observed no significant differences in overall developmental outcomes or behavior in exposed versus unexposed children.

By |2024-06-26T12:57:54-04:00March 27th, 2024|Antipsychotic Medications, Child Outcomes, Neurodevelopmental Disorders, Outcomes, Pregnancy & Medications, Research at CWMH|Comments Off on Research from the CWMH: Prenatal Exposure to Second Generation Antipsychotics and Neurodevelopmental Outcomes in Preschool-Aged Children

Danish Study Indicates No Increase in Risk of Malformations with Prenatal Exposure to Antipsychotic Medications

This register-based cohort study from Denmark of 503,158 clinically recognized pregnancies observed little or no risk of teratogenesis associated with first trimester exposure to antipsychotic medications.

By |2024-06-26T13:02:08-04:00January 31st, 2024|Antipsychotic Medications, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Danish Study Indicates No Increase in Risk of Malformations with Prenatal Exposure to Antipsychotic Medications

Essential Reads: Modafinil and Armodafinil During Pregnancy Associated with Increased Risk of Malformations

Modafinil (brand name Provigil) and armodafinil (Nuvigil) are wake-promoting agents used to treat sleepiness due to narcolepsy, shift work sleep disorder, or obstructive sleep apnea. They are also used in other settings, often in [...]

By |2024-05-16T07:00:11-04:00October 11th, 2023|ADHD Medications, Essential Reads, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Essential Reads: Modafinil and Armodafinil During Pregnancy Associated with Increased Risk of Malformations

Neurodevelopmental Outcomes in Infants Exposed During Pregnancy to ADHD Medications

Prenatal exposure to ADHD medications, mostly methylphenidate, was not associated with an increased risk of neurodevelopmental disorders or growth restriction in exposed children.

By |2023-10-03T12:00:00-04:00October 11th, 2023|ADHD Medications, Neurodevelopmental Disorders, Outcomes, Pregnancy & Medications|Comments Off on Neurodevelopmental Outcomes in Infants Exposed During Pregnancy to ADHD Medications

New Study Investigates the Impact of Prenatal SSRI Exposure on Brain Structure in Older Children

Maternal SSRI use during pregnancy may be associated with altered brain development in children; however, this study cannot fully rule out contributions of confounding genetic and enviromental factors.

By |2024-06-26T13:12:36-04:00September 27th, 2023|Long-Term Outcomes, Outcomes, Pregnancy & Medications|Comments Off on New Study Investigates the Impact of Prenatal SSRI Exposure on Brain Structure in Older Children

New Research from the CWMH: Risk of Major Malformations in Infants with Prenatal Exposure to Benzodiazepines

Data from an ongoing pregnancy registry offers reassurance that benzodiazepines do not appear to have major teratogenic effects.

By |2023-06-27T17:47:46-04:00June 26th, 2023|Anti-Anxiety Medications, Outcomes, Pregnancy & Medications, Research at CWMH, Risk of Malformations|Comments Off on New Research from the CWMH: Risk of Major Malformations in Infants with Prenatal Exposure to Benzodiazepines
Go to Top